Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Siokas, V., Tsouris Z., Aloizou A-M., Bakirtzis C., Liampas I., Koutsis G., et al. (2020).  Multiple Sclerosis: Shall We Target CD33?. Genes (Basel). 11(11), 
Sinz, C., Tschandl P., Rosendahl C., Akay B. Nisa, Argenziano G., Blum A., et al. (2017).  Accuracy of dermatoscopy for the diagnosis of nonpigmented cancers of the skin.. J Am Acad Dermatol. 77(6), 1100-1109.
Singh, B., Lodhi A., Choi C., Bonington A., & Kosmidis C. (2017).  Use of voriconazole in non-meningeal cryptococcosis.. Infect Dis (Lond). 49(9), 702-704.
Sinapidis, D., Kosmas V., Vittoros V., Koutelidakis I. M., Pantazi A., Stefos A., et al. (2018).  Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection.. BMC Infect Dis. 18(1), 242.
Sinakos, E., Marschall H-U., Kowdley K. V., Befeler A., Keach J., & Lindor K. (2010).  Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.. Hepatology. 52(1), 197-203.
Sinakos, Ε., Gioula G., Liava C., Papa A., Papadopoulou E., Tsakni E., et al. (2018).  Prevalence of hepatitis E in liver transplant recipients in Greece.. Epidemiol Infect. 146(13), 1619-1621.
Sinakos, E., Saenger A. K., Keach J., W Kim R., & Lindor K. D. (2011).  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.. Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
Sinakos, E., Dedes I., Papalavrentios L., Drevelegas A., & Akriviadis E. (2010).  Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.. Scand J Gastroenterol. 45(4), 511-2.
Sinakos, E., Gigi E., Lalla T., Bellou A-L., Sykja A., Orphanou E., et al. (2010).  Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment.. Hippokratia. 14(2), 122-5.
Sinakos, E., Abbas G., Jorgensen R. A., & Lindor K. D. (2012).  Serum lipids in primary sclerosing cholangitis.. Dig Liver Dis. 44(1), 44-8.
Sinakos, E., Panas P., Fragkou N., Antoniadis N., Katsanos G., Tsakni E., et al. (2022).  Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease.. Acta Gastroenterol Belg. 85(2), 331-337.
Sinakos, E., Selvaggi G., Papalavrentios L., Tzakis A., & Akriviadis E. (2011).  The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence.. Ann Gastroenterol. 24(3), 228-230.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Sinakos, E., & Lindor K. D. (2010).  Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?. Am J Gastroenterol. 105(3), 596-8.
Sinakos, E., Papalavrentios L., Chourmouzi D., Dimopoulou D., Drevelegas A., & Akriviadis E. (2011).  The clinical presentation of Von Meyenburg complexes.. Hippokratia. 15(2), 170-3.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Sinakos, E., Samuel S., Enders F., Loftus E. V., Sandborn W. J., & Lindor K. D. (2013).  Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship.. Inflamm Bowel Dis. 19(5), 1004-9.
Sinakos, E., Vlachaki E., & Tsapas A. (2012).  Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.. Br J Haematol. 157(4), 505-6; author reply 506-7.
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Sinakos, E., & Lindor K. (2010).  Treatment options for primary sclerosing cholangitis.. Expert Rev Gastroenterol Hepatol. 4(4), 473-88.
Sinakos, E., Hytiroglou P., Stachteas P., Liava C., & Akriviadis E. (2019).  The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis.. Eur J Gastroenterol Hepatol. 31(7), 897-898.
Simoncini, T., Cano A., Goulis D. G., Lambrinoudaki I., Rees M., & Stute P. (2019).  On the use and abuse of register studies: The case of menopausal hormone therapy.. Maturitas. 123, 91-92.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2011).  The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.. Int J Geriatr Psychiatry. 26(1), 75-82.
Simmons, A., Westman E., Muehlboeck S., Mecocci P., Vellas B., Tsolaki M., et al. (2009).  MRI measures of Alzheimer's disease and the AddNeuroMed study.. Ann N Y Acad Sci. 1180, 47-55.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές